The Global Paradise System Registry (GPS Registry)
The Global Paradise® System Registry
Sponsor: ReCor Medical, Inc.
This observational or N/A phase trial investigates Hypertension and is currently actively recruiting participants. ReCor Medical, Inc. leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Aug 2023 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Feb 2022 — Sep 2022 [monthly]
Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Jan 2022 [monthly]
Not Yet Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ReCor Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Alkmaar, Netherlands , Bad Krozingen, Germany , Berlin, Germany , Bordeaux, France , Bournemouth, United Kingdom , Brussels, Belgium , Canterbury, United Kingdom , Cardiff, United Kingdom , Coburg, Germany and 23 more locations